Richard Daniell sold $3.3M of Teva Pharmaceutical Industries Limited (TEVA)

Executed Dec 9 2025, disclosed Dec 11 2025, 2 days later.

Value, as filed

$3.3M

115,468 sh × $28.68

Executed

Dec 9 2025

the trade date, as filed

Disclosed

Dec 11 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Richard Daniell Exec. VP, European Commercial profile →

Richard Daniell (Exec. VP, European Commercial) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Teva Pharmaceutical Industries Limited (TEVA). The largest single filing was $4.2M of TEVA (128,985 sh across 2 lots, as filed), executed Mar 3.

The name

TEVA

Teva Pharmaceutical Industries Limited TEVA · Healthcare · 60 filings in 24 months ticker →

Healthcare · Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Richard Daniell in TEVA

TEVASALE Teva Pharmaceutical Industries Limited $1.1M
30,000 sh × $35.40
Exec May 5
Filed May 7 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $548K
17,295 sh × $31.67
Exec Mar 5
Filed Mar 9 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $3.0M
91,345 sh across 3 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $4.2M
128,985 sh across 2 lots
Exec Mar 3
Filed Mar 5 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $1.1M
70,961 sh across 2 lots
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $2.2M
140,372 sh across 6 lots
Exec Mar 4 2025
Filed Mar 6 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $1000K
62,250 sh across 2 lots
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET